quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:15:00·36d
PRRelease
Aditxt Inc. logo
Global Medical REIT Inc. logo
Chiron Real Estate Inc. logo

Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer

ADTX· Aditxt Inc.GMRE· Global Medical REIT Inc.XRN· Chiron Real Estate Inc.
Health CareReal Estate
Original source

Companies

  • ADTX
    Aditxt Inc.
    Health Care
  • GMRE
    Global Medical REIT Inc.
    Real Estate
  • XRN
    Chiron Real Estate Inc.
    Real Estate

Recent analyst ratings

  • Oct 13GMREUpdateCitizens JMP$40.00
  • Apr 3GMREUpdateB. Riley Securities$9.00
  • Oct 18GMREUpdateBerenberg$11.75
  • Sep 19GMREUpdateAlliance Global Partners$12.00
  • Oct 10GMREUpdateRobert W. Baird$9.00
  • Oct 6GMREUpdateBMO Capital Markets$9.00

Related

  • SEC18h
    SEC Form 424B3 filed by Aditxt Inc.
  • INSIDER19h
    Large owner Hrt Financial Lp bought $24,061 worth of Class A Shares (72,912 units at $0.33) and sold $3,595 worth of Class A Shares (11,982 units at $0.30), increasing direct ownership by 100% to 121,592 units (SEC Form 4)
  • INSIDER19h
    New insider Hrt Financial Lp claimed ownership of 133,574 units of Class A Shares (SEC Form 3)
  • SEC2d
    SEC Form EFFECT filed by Aditxt Inc.
  • PR8d
    Chiron Real Estate Inc. Announces Dates for 2026 First Quarter Earnings Release and Webcast
  • SEC10d
    Aditxt Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
  • SEC13d
    SEC Form S-3 filed by Aditxt Inc.
  • SEC15d
    SEC Form DEFA14A filed by Chiron Real Estate Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022